Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor
Open Access
- 1 January 2017
- journal article
- case report
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 56 (13), 1673-1678
- https://doi.org/10.2169/internalmedicine.56.7945
Abstract
We herein present the case of a 21-year-old diabetic obese woman who developed ketoacidosis following the administration of ipragliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor. At the time of admission, although her serum glucose level was only 175 mg/dL, laboratory tests showed ketoacidosis. Interestingly, hyperglycosuria persisted, even after the discontinuation of ipragliflozin. This is the first report of non-hyperglycemic ketoacidosis that might have been caused by protracted hyperglycosuria after the discontinuation of ipragliflozin. The development of non-hyperglycemic ketoacidosis should be monitored following the discontinuation of SGLT2 inhibitors, especially in patients who start to feel unwell and exhibit protracted hyperglycosuria after the discontinuation of treatment.Keywords
This publication has 28 references indexed in Scilit:
- Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose productionJCI Insight, 2014
- Urinary tract infections in patients with diabetes treated with dapagliflozinJournal of Diabetes and its Complications, 2013
- Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 DiabetesAnnals of Internal Medicine, 2013
- Dapagliflozin a glucose‐regulating drug with diuretic properties in subjects with type 2 diabetesDiabetes, Obesity and Metabolism, 2013
- Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and ExerciseDiabetes Care, 2010
- Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weightDiabetes, Obesity and Metabolism, 2010
- Sodium Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 2010
- The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveysInternational Journal of Clinical Practice, 2007
- Metabolic Effects of Low-Dose Insulin Therapy on Glucose Metabolism in Diabetic KetoacidosisDiabetes, 1988
- Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosisDiabetes, 1988